Instant coffee and powdered milk are produced by spray drying. Fraunhofer researchers have adapted this technique to the tricky question of incorporating insoluble substances in core-shell particles. The new method helps reduce the concentration of active ingredients in therapeutic medications.
Encapsulation is used in cosmetics and pharmaceuticals to protect active ingredients against external influences such as aggressive gastric acid. Another use of encapsulation is to control the release of active ingredients inside the body: depending on the permeability of the shell material, the medication is delivered gradually rather than all at once. Because such systems release multiple, smaller doses over an extended period of time, the drug therapy is better tolerated and easier to administer. In some cases, it means taking just one pill a day instead of three.
Insoluble substances are a problem
The first step of the encapsulation process involves dissolving the active ingredient in a liquid medium and mixing it with the shell material. Then the solution is piped to an orifice in the center of a nozzle surrounded by an annular channel through which compressed air is injected at high speed. The pressure disperses the solution into an aerosol of fine droplets, which is then sprayed into a drying cylinder. Here, the liquid evaporates, leaving behind a fine powder of core-shell particles. The problem is that it is difficult to mix insoluble substances with other materials. This limits the choice of shell materials that can be used to produce the particles.
Three-way nozzle permits endless combinations of materials
“For this reason, we use a three-way nozzle to implement spraying. Its advantage is that it permits two substances to be fed separately to the nozzle. The shear forces mix the substances together at the orifice of the nozzle, creating an aerosol containing both materials,” explains Michael Walz, who developed and optimized the new technique with his colleague Dr. Achim Weber at the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB in Stuttgart.
This system permits endless combinations of materials, enabling the controlled release of active ingredients to be adapted to different applications. “We can modify the particle size and encapsulation efficiency by selecting the appropriate substances and by varying the concentration of the solution, the liquid volume flow, the drying temperature, and the pressure applied to the nozzle. This gives us the capability to respond to almost any customer requirement and develop solutions tailored to their needs,” says Weber.
The new process for the encapsulation of active ingredients could be of interest to fertilizer manufacturers and food processing companies as well as the cosmetics and pharmaceutical industries.
The Latest on: Drug delivery
- Global drug delivery devices market is poised to reach USD 1,495.31 billion by 2021 according to new research report on January 17, 2018 at 11:13 pm
The Global market for Drug Delivery Technology is expected to reach USD 1,495.31 Billion by 2021 from the estimated value of USD 1086.8 Billion in 2016 growing at a CAGR 6.59 % during forecast period. Drugs can be managed directly into the body through ... […]
- Novel drug-release system allows precision delivery to subcutaneous cancers on January 16, 2018 at 9:27 pm
The findings of a new study by Swedish and Chinese researchers into a novel photosensitization-based drug-release system could bring about broad changes in the delivery of cancer therapies, with millions of patients worldwide potentially benefiting from ... […]
- Delivra develops a revolutionary topical cream utilizing cannabis and opioid molecules for safer delivery in patients with chronic pain and anxiety on January 16, 2018 at 3:00 am
"Our goal is to develop innovative products using our proprietary topical delivery platform (Delivra TM ... statements regarding: the Company's drug research and development plans; the timing of operations; and estimates of market conditions. […]
- Novel Drug Delivery Systems in Cancer Therapy Market Worth $26.6 Billion by 2025: Grand View Research, Inc. on January 15, 2018 at 4:17 am
The global novel drug delivery systems (NDDS) in cancer therapy market is expected to reach USD 26.61 billion by 2025, according to a new report by Grand View Research, Inc. The market is primarily driven by global rise in incidence of cancer, increase in ... […]
- Man facing drug delivery resulting in death charge arrested again on January 12, 2018 at 7:01 am
Two men face drug-related charges after they were found Thursday in Hazleton with various controlled substances along with cash and other items, according to city police. One of the men, Kyle Merenda, 23, of Barnesville, is awaiting trial in Schuylkill ... […]
- Latest Report of Drug Delivery Technologies Market Size & Share, Growth, Trends and Forecast for next 5 years on January 12, 2018 at 1:05 am
HTF MI published a new industry research that focuses on Drug Delivery Technologies market and delivers in-depth market analysis and future prospects of Global Drug Delivery Technologies market. The study covers significant data which makes the research ... […]
- Lyndra Announces Publication of Feasibility Study of Oral Once-Weekly Drug Delivery System for HIV Antiretroviral Therapy in Nature Communications on January 11, 2018 at 7:15 pm
WATERTOWN, Mass.--(BUSINESS WIRE)--Lyndra Inc., an emerging biopharmaceutical company developing oral dosage forms designed to release drug for up to a week or longer, today announced the publication of a feasibility study of an oral, once-weekly drug ... […]
- Erie man held for court in drug delivery death case on January 10, 2018 at 1:30 pm
An Erie police drug investigator testified on Wednesday that evidence including a cell phone number and pieces of a pharmacy prescription paperwork helped detectives tie a city man to narcotics that caused a woman's overdose death in Millcreek Township in ... […]
- BRIEF-FDA Approves Innovative Clinician Programmer For The Medtronic Synchromed II Intrathecal Drug Delivery System on January 10, 2018 at 4:26 am
Jan 10 (Reuters) - Medtronic Plc: * FDA APPROVES INNOVATIVE CLINICIAN PROGRAMMER FOR THE MEDTRONIC SYNCHROMED II INTRATHECAL DRUG DELIVERY SYSTEM FOR CHRONIC PAIN AND SEVERE SPASTICITY Source text for Eikon: Further company coverage: Our Standards:The ... […]
via Google News and Bing News